EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effects of subcutaneous and sublingual allergen immunotherapy on immune responses in children with bronchial asthma

Jinfeng Wei, Cuiying Ye, Xiangying Wang, Li Zhang, Suling Wu, Xuefeng Jin

Asian Pacific Journal of Allergy and Immunology · 2026

DOI: 10.12932/ap-050625-2089 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2026. Verfasst von Jinfeng Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respirology, Hangzhou Children's Hospital. Hauptthemen laut MEDLINE: Asthma, Desensitization, Immunologic, Allergens, Sublingual Immunotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Allergic asthma in children significantly impacts quality of life, and immunotherapy, including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), has emerged as an effective treatment. However, their comparative immunological mechanisms remain unclear. OBJECTIVE: This study aimed to compare the effects of SCIT and SLIT on immune response in children with allergic asthma and to explore their underlying immunological mechanisms. METHODS: A total of 86 children aged 5-12 years with allergic asthma who visited Hangzhou Children's Hospital were prospectively enrolled and randomly assigned to three groups: inhaled corticosteroids (ICS) group (n = 30), SCIT group (n = 30), and SLIT group (n = 26). Clinical and immunological parameters-including Childhood Asthma Control Test (C-ACT) scores, forced expiratory volume in the first second percentage (FEV1%), Th17, Treg cells, and serum levels of IL-17, IL-9, IL-10-were assessed before treatment and after one year. RESULTS: After treatment, all three groups showed significant improvements in C-ACT scores and FEV1% compared to baseline (all p 0.05). In terms of immune markers, significant differences were observed in all parameters before and after treatment in the SCIT and SLIT groups (all p 0.05). No statistically significant differences in immune markers were found among the three groups post-treatment (all p >0.05). CONCLUSIONS: Both SCIT and SLIT, when combined with ICS, offer superior efficacy compared to ICS monotherapy. The comparable immunological changes observed in SCIT and SLIT suggest a shared mechanism of immune tolerance, potentially mediated through Treg cell induction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaDesensitization, ImmunologicAllergensSublingual ImmunotherapyHumansChildFemaleMaleChild, PreschoolInjections, SubcutaneousTreatment OutcomeAdministration, SublingualCytokinesT-Lymphocytes, Regulatory

Substanzen

AllergensCytokines

Autor:innen und Institutionen

  • Department of Respirology, Hangzhou Children's Hospital.
  • Clinical Lab, Hangzhou Children's Hospital.
  • Department of Gastroenterology, Hangzhou Children's Hospital.

Zitieren

APA

Wei, J., Ye, C., Wang, X., Zhang, L., Wu, S., & Jin, X. (2026). Effects of subcutaneous and sublingual allergen immunotherapy on immune responses in children with bronchial asthma. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/ap-050625-2089

Vancouver

Wei J, Ye C, Wang X, Zhang L, Wu S, Jin X. Effects of subcutaneous and sublingual allergen immunotherapy on immune responses in children with bronchial asthma. Asian Pacific Journal of Allergy and Immunology. 2026. doi:10.12932/ap-050625-2089

BibTeX
@article{Wei2026,
  author = {Wei, Jinfeng and Ye, Cuiying and Wang, Xiangying and Zhang, Li and Wu, Suling and Jin, Xuefeng},
  title = {Effects of subcutaneous and sublingual allergen immunotherapy on immune responses in children with bronchial asthma},
  journal = {Asian Pacific Journal of Allergy and Immunology},
  year = {2026},
  doi = {10.12932/ap-050625-2089}
}
Kostenlos starten →